KYNAMRO for Type iia hyperlipidaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 40 adverse event reports in the FDA FAERS database where KYNAMRO was used for Type iia hyperlipidaemia.
Most Reported Side Effects for KYNAMRO
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Injection site erythema | 12 | 24.0% | 0 | 1 |
| Drug dose omission | 11 | 22.0% | 0 | 3 |
| Influenza like illness | 9 | 18.0% | 0 | 0 |
| Injection site pain | 9 | 18.0% | 0 | 0 |
| Injection site pruritus | 8 | 16.0% | 0 | 1 |
| Hepatic enzyme increased | 7 | 14.0% | 0 | 1 |
| Injection site discolouration | 5 | 10.0% | 0 | 1 |
| Liver function test abnormal | 5 | 10.0% | 0 | 0 |
| Pain | 5 | 10.0% | 0 | 0 |
Other Indications for KYNAMRO
Other Drugs Used for Type iia hyperlipidaemia
EVOLOCUMAB (5,556)
LOMITAPIDE (3,314)
ALIROCUMAB (1,913)
ATORVASTATIN (637)
EZETIMIBE (562)
ROSUVASTATIN (547)
INCLISIRAN (313)
SIMVASTATIN (294)
PRAVASTATIN (152)
JUXTAPID (145)